Malaysia eye drop market is anticipated to grow significantly in the projected period of 2028. Malaysia's eye drop market has experienced significant growth in recent years. This can be attributed to an increase in eye-related disorders, increased awareness of eye health, and the introduction of new and advanced eye drop products in the market. Eye drops are liquid drops that are typically applied in small amounts, such as one or a few drops, directly to the surface of the eye. Saline is typically present in eye drops to match the salinity of the eye. Artificial tears, or drops containing only saline and occasionally a lubricant, are frequently used to treat dry eyes or mild eye irritation like itching or redness. Several different eye diseases can be treated with eye drops that also contain one or more medications. Due to the increased demand for eye drops and related products, the Malaysia eye drop market is flourishing. The rising incidence of eye diseases is another factor influencing the expansion of the Malaysian eye drop market. In Malaysia, the prevalence of myopia among children and young adults has increased along with age-related eye diseases. Growing awareness of the significance of eye health is another factor driving growth in the Malaysian eye drop market, in addition to aging population and increase in the prevalence of eye diseases. As people age, the risk of developing eye diseases such as cataracts, glaucoma, and age-related macular degeneration increases.
According to the World Bank, in 2020, more than 7% of the population was over 65, which met the standard definition of an "ageing society" used internationally. Malaysia will be an "aged society" by 2044, where 14% of the population is predicted to be over 65 and by 2056. Malaysia will be a "super-aged society" with more than 20% of the population being over 65.
Rising Geriatric Population is Expanding the Malaysian Eye Drop Market
According to the National Health and Morbidity Survey 2019, in Malaysia, type 2 diabetes (T2D) prevalence has increased to 20.8% in persons over the age of 30, affecting 2.8 million people
Rising Prevalence of Eye Diseases is Booming the Malaysia Eye Drop Market
According to the National Library of Medicines, in 2022, the prevalence of cataract among older people was 26.8%
Recent Development
- In November 2021, with the FDA's approval, AbbVie's Vuity for presbyopia became the first eye drop treatment for the widespread eye condition. With its pHast proprietary technology, which AbbVie uses for Vuity, the medication can quickly adapt to the pH of the tear film.
Download Free Sample Report
Market Segmentation
Malaysia eye drop market is segmented into type, drug class, disease indication, distribution channel, region, and company. Based on type, Malaysia eye drop market is divided into prescription and over the counter. Based on drug class, Malaysia eye drop market is categorized into antiallergy, anti-inflammatory, antiglaucoma, anti-VEGF, and others. Based on disease indication, Malaysia eye drop market is categorized into dry eye diseases, glaucoma, eye allergy, eye infections, retinal disorders, and others. Based on distribution channel, Malaysia eye drop market is categorized into hospitals pharmacy, retail pharmacy, and online pharmacy. Based on region, the Malaysia eye drop market is segmented into the East Malaysia and West Malaysia.
Company Profiles
Alcon Laboratories (Malaysia) Sdn Bhd, Johnson & Johnson, CooperVision Contact Lens Malaysia Sdn Bhd, Metro optical Group Eyeware, TRB CHEMEDICA, Xepa Laboratories Pte. Ltd, Thea Pharma Sdn Bhd, Systane, and Rohto are some of the key players of Malaysia eye drop market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, volume forecasting, Company shares, competitive landscape, growth factors, and trends |
Segments Covered | Type Drug Class Disease Indication Distribution Channel |
Country Scope | The East Malaysia and The West Malaysia |
Key Companies Profiled | Alcon Laboratories (Malaysia) Sdn Bhd, Johnson & Johnson, CooperVision Contact Lens Malaysia Sdn Bhd, Metro optical Group Eyeware, TRB CHEMEDICA, Xepa Laboratories Pte. Ltd, Thea Pharma Sdn Bhd, Systane, Rohto |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |